KELLY TALARICO: Open Payments
NPI 1720605439 · ALCOA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 16 payments from 10 companies in 2025. Trend: 2023 $230 · 2024 $119 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Lundbeck LLC | 1 | $24 |
| PFIZER INC. | 1 | $22 |
| Neos Therapeutics, LP | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Exact Sciences Corporation | 1 | $14 |
Products named: Auvelity, TRINTELLIX, INGREZZA, SPRAVATO, REXULTI, ELIQUIS, EXXUA, AUSTEDO XR.
Industry payments across TN — which companies pay providers there.
